檢索結果 - S. Piha-Paul
- Showing 1 - 20 results of 249
- Go to Next Page
-
1
-
2
-
3
-
4
Quantitative analysis of taxane drug target engagement of microtubules in circulating tumor cells from metastatic castration resistant prostate cancer patients treated with CRXL301... 由 Mukhtar, Eiman, Worroll, Daniel, Galletti, Giuseppe, Schuster, Shelly, Piha-Paul, Sarina A., Giannakakou, Paraskevi
出版 2020Text -
5
-
6
-
7
-
8
Pediatric Patients with Refractory Central Nervous System Tumors: Experiences of a Clinical Trial Combining Bevacizumab and Temsirolimus 由 Piha-Paul, Sarina A., Shin, Sang Joon, Vats, Tribhawan, Guha-Thakurta, Nandita, Aaron, Joann, Rytting, Michael, Kleinerman, Eugenie, Kurzrock, Razelle
出版 2014Text -
9
Phase I trial of MEK 1/2 inhibitor pimasertib combined with mTOR inhibitor temsirolimus in patients with advanced solid tumors 由 Mita, Monica, Fu, Siqing, Piha-Paul, Sarina Anne, Janku, Filip, Mita, Alain, Natale, Ronald, Guo, Wei, Zhao, Charles, Kurzrock, Razelle, Naing, Aung
出版 2017Text -
10
-
11
-
12
-
13
-
14
Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimus 由 Piha-Paul, Sarina A., Wheler, Jennifer J., Fu, Siqing, Levenback, Charles, Lu, Karen, Falchook, Gerald S., Naing, Aung, Hong, David S., Tsimberidou, Apostolia M., Kurzrock, Razelle
出版 2014Text -
15
Survival of 1,181 Patients in a Phase I Clinic: The MD Anderson Clinical Center for Targeted Therapy Experience 由 Wheler, Jennifer, Tsimberidou, Apostolia M., Hong, David, Naing, Aung, Falchook, Gerald, Piha-Paul, Sarina, Fu, Siqing, Moulder, Stacy, Stephen, Bettzy, Wen, Sijin, Kurzrock, Razelle
出版 2012Text -
16
The Effect of Renal Impairment on the Pharmacokinetics and Safety of Talazoparib in Patients with Advanced Solid Tumors 由 Durairaj, Chandrasekar, Chakrabarti, Jayeta, Ferrario, Cristiano, Hirte, Holger W., Babu, Sunil, Piha-Paul, Sarina A., Plotka, Anna, Hoffman, Justin, Shi, Haihong, Wang, Diane D.
出版 2021Text -
17
Evaluation of pharmacokinetics and safety of talazoparib in patients with advanced cancer and varying degrees of hepatic impairment 由 Guo, Cen, Yu, Yanke, Chakrabarti, Jayeta, Piha‐Paul, Sarina A., Moroose, Rebecca, Plotka, Anna, Shi, Haihong, Durairaj, Chandrasekar, Wang, Diane D., Wainberg, Zev A.
出版 2022Text -
18
Aberrations in the epidermal growth factor receptor gene in 958 patients with diverse advanced tumors: implications for therapy 由 Wheler, J. J., Falchook, G. S., Tsimberidou, A. M., Hong, D. S., Naing, A., Piha-Paul, S. A., Chen, S. S., Fu, S., Stephen, B., Fok, J. Y., Janku, F., Kurzrock, R.
出版 2013Text -
19
Combining Erlotinib and Cetuximab is Associated with Activity in Patients with Non Small Cell Lung Cancer (including Squamous Cell Carcinomas) and Wild-Type EGFR or Resistant Mutat... 由 Wheler, Jennifer J., Tsimberidou, Apostolia M., Falchook, Gerald S., Zinner, Ralph G., Hong, David S., Fok, Jansina Y., Fu, Siqing, Piha-Paul, Sarina A., Naing, Aung, Kurzrock, Razelle
出版 2013Text -
20
Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer 由 Meric-Bernstam, Funda, Johnson, Amber M., Dumbrava, Ecaterina E. Ileana, Raghav, Kanwal P., Balaji, Kavitha, Bhatt, Michelle, Murthy, Rashmi K., Rodon, Jordi, Piha-Paul, Sarina A.
出版 2018Text
相關主題
Medicine
Internal medicine
Oncology
Cancer
Biology
Cancer research
Clinical trial
Gastroenterology
Gene
Immunotherapy
Adverse effect
Genetics
Pembrolizumab
Biochemistry
Pharmacology
Colorectal cancer
Pathology
Response Evaluation Criteria in Solid Tumors
Surgery
Breast cancer
Clinical endpoint
Chemotherapy
Mutation
PI3K/AKT/mTOR pathway
Phases of clinical research
Bioinformatics
KRAS
Tolerability
Confidence interval
Signal transduction